Evaluation of Alternative Antimalarial Drugs for Malaria in Pregnancy
Evaluation of the Safety and Efficacy of Mefloquine as Intermittent Preventive Treatment of Malaria in Pregnancy
Sponsor: Albert Schweitzer Hospital
Listed as NCT00811421, this NA trial focuses on HIV Infections and Malaria and remains completed. Sponsored by Albert Schweitzer Hospital, it has been updated 5 times since 2009, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Jun 2018 — Jan 2021 [monthly]
Completed NA
-
Jan 2017 — Jun 2018 [monthly]
Completed NA
First recorded
Sep 2009
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Albert Schweitzer Hospital
- Barcelona Centre for International Health Research
- Centers for Disease Control and Prevention
- Centro de Investigacao em Saude de Manhica
- Hospital Clinic of Barcelona
- Ifakara Health Institute
- Institut de Recherche pour le Developpement
- Institute of Tropical Medicine, University of Tuebingen
- Kenya Medical Research Institute
- Malaria in Pregnancy Consortium
- Université d'Abomey-Calavi
- Vienna School of Clinical Research (VSCR), Austria.
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
- • Allada, Benin
- • Dodoma, Tanzania
- • Kisumu, Kenya
- • Lambaréné, Gabon
- • Manhiça, Mozambique